2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, O Kowal‐Bielecka, U MüllerLadner… - Arthritis & …, 2013 - Wiley Online Library
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, Z Li, X Mariette, U Müller-Ladner… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

…, DF Bancel, Y Allanore, U Müller-Ladner… - Annals of the …, 2010 - ard.bmj.com
Objectives To determine the causes and predictors of mortality in systemic sclerosis (SSc).
Methods Patients with SSc (n=5860) fulfilling the American College of Rheumatology criteria …

Update of EULAR recommendations for the treatment of systemic sclerosis

…, UA Walker, F Zulian, U Müller-Ladner - Annals of the …, 2017 - ard.bmj.com
The aim was to update the 2009 European League against Rheumatism (EULAR)
recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic …

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when …

…, SJ Lee, HU Kim, W Park, U Müller-Ladner - Annals of the …, 2013 - ard.bmj.com
Objectives To compare the efficacy and safety of innovator infliximab (INX) and CT-P13, an
INX biosimilar, in active rheumatoid arthritis patients with inadequate response to …

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

…, O Distler, D Khanna, U Müller-Ladner… - Annals of the …, 2014 - ard.bmj.com
Objective Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death
in systemic sclerosis (SSc), facilitates earlier treatment. The objective of this study was to …

Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

…, S Gay, J Schölmerich, T Pap, U Müller-Ladner… - Nature medicine, 2009 - nature.com
Active rheumatoid arthritis originates from few joints but subsequently affects the majority of
joints. Thus far, the pathways of the progression of the disease are largely unknown. As …

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

…, AB Olesen, JC Henes, U Müller-Ladner… - The Lancet …, 2020 - thelancet.com
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

…, RBM Landewé, A Molto, U Müller-Ladner… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for vaccination
in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, M Inanc, O Kowal‐Bielecka, U MüllerLadner… - 2013 - deepblue.lib.umich.edu
Objective. The 1980 American College of Rheuma-tology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …